Integrated Environmental Technologies 10-Q 7 Nov 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Nov. 05, 2014
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'INTEGRATED ENVIRONMENTAL TECHNOLOGIES, LTD.	'
Entity Central Index Key	'0001084031	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--12-31	'
Document Period End Date	30-Sep-14	'
Document Type	'10-Q	'
Document Fiscal Period Focus	'Q3	'
Document Fiscal Year Focus	'2014	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	252,765,411

Consolidated_Balance_Sheets_Un

Consolidated Balance Sheets (Unaudited) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Current assets:	'	'
Cash	$533,568	$1,049,399
Accounts receivable	38,848	28,250
Prepaid expenses	12,789	26,166
Inventory	123,647	126,952
Total current assets	708,852	1,230,767
Property and equipment, net	280,822	344,884
Total assets	989,674	1,575,651
Current liabilities:	'	'
Accounts payable	129,208	41,320
Accrued expenses	74,119	47,954
Customer deposits	38,109	38,109
Convertible debentures	501,125	25,000
Note payable	65,920	75,513
Total current liabilities	808,481	227,896
Convertible debentures	'	476,125
Note payable	'	46,546
Total liabilities	808,481	750,567
Commitments and contingencies	'	'
Stockholders' equity:	'	'
Common stock, $.001 par value; 400,000,000 shares authorized; 246,376,594 and 229,971,926 shares issued and outstanding, respectively	246,377	229,972
Additional paid-in capital	20,873,462	20,075,764
Accumulated deficit	-20,938,646	-19,480,652
Total stockholders' (deficiency) equity	181,193	825,084
Total liabilities and stockholders' (deficiency) equity	$989,674	$1,575,651

Consolidated_Balance_Sheets_Un1

Consolidated Balance Sheets (Unaudited) (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Balance Sheets [Abstract]	'	'
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares issued	246,376,594	229,971,926
Common stock, shares outstanding	246,376,594	229,971,926

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenues:	'	'	'	'
Sales	$39,545	$31,942	$93,988	$76,648
Leasing and licensing fees	11,000	10,500	23,000	46,500
Total revenues	50,545	42,442	116,988	123,148
Cost of sales	10,424	9,462	42,155	24,110
Gross profit	40,121	32,980	74,833	99,038
Operating expenses:	'	'	'	'
General and administrative	310,590	307,413	887,649	959,217
Sales and marketing	162,018	119,669	444,240	334,992
Research and development	52,187	55,450	164,078	154,841
Total operating expenses	524,795	482,532	1,495,967	1,449,050
Loss from operations	-484,674	-449,552	-1,421,134	-1,350,012
Other income (expense):	'	'	'	'
Interest income	'	3	'	55
Interest expense	-11,844	-12,014	-36,860	-33,072
Total other income (expense)	-11,844	-12,011	-36,860	-33,017
Net loss	($496,518)	($461,563)	($1,457,994)	($1,383,029)
Net loss per share, basic and diluted	$0	$0	($0.01)	($0.01)
Weighted average shares outstanding, basic and diluted	239,470,030	198,329,568	233,590,838	175,460,264

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:	'	'
Net loss	($1,457,994)	($1,383,029)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'
Depreciation and amortization	64,062	126,549
Stock-based compensation expense	66,778	116,505
Stock issued as settlement of litigation	'	26,550
Changes in operating assets and liabilities:	'	'
Accounts receivable	-18,098	-12,624
Inventory	3,305	-2,510
Prepaid expenses	13,377	-20,424
Note receivable	'	1,109
Accounts payable	127,638	-35,083
Accrued expenses	17,615	-45,976
Customer deposits	'	2,000
Net cash used in operating activities	-1,183,317	-1,226,933
Cash flows used in investing activity:	'	'
Purchase of equipment	'	-66,507
Cash flows from financing activities:	'	'
Proceeds from sale of common stock, net of offering costs	723,625	1,672,605
Repayment of note payable	-56,139	-11,872
Net cash provided by financing activities	667,486	1,660,733
(Decrease) increase in cash	-515,831	367,293
Cash - beginning of period	1,049,399	180,489
Cash - end of period	533,568	547,782
Supplemental disclosure of cash flow information:	'	'
Cash paid for interest	6,117	803
Cash paid for income taxes	700	106
Non-cash operating activity:	'	'
Issuance of 492,614 and 1,485,714 shares of common stock, respectively, as payment of director fees	32,250	70,250
Issuance of 400,947 shares of common stock as payment of interest on convertible debenture	'	38,090
Non-cash investing activity	'	'
Issuance of note payable as payment of equipment	'	$152,000

Consolidated_Statements_of_Cas1

Consolidated Statements of Cash Flows (Unaudited) (Parenthetical)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Statement of Cash Flows [Abstract]	'	'
Common stock issued as payment of director fees, shares	492,614	1,485,714
Common stock shares issued as payment of interest on convertible debenture	'	400,947

Basis_of_Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2014
Basis of Presentation [Abstract]	'
Basis of Presentation	'
	1.     Basis of Presentation
	The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred significant recurring operating losses and negative cash flows from operations. The Company had working capital deficiency of $99,629 and an accumulated deficit of $20,938,646 as of September 30, 2014. The Company also has no lending relationships with commercial banks and is dependent on the completion of financings involving the private placement of its securities in order to continue operations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
	The Company does not anticipate establishing any lending relationships with commercial banks in the foreseeable future due to its limited operations and assets. The Company continues to execute its strategy of selling anolyte and catholyte solutions and leasing its EcaFlo™ equipment to fund its operations and is focused on obtaining additional capital through the private placement of its securities. The Company is pursuing potential equity and/or debt investors and, from time to time, has engaged placement agents to assist it in this initiative. While the Company is pursuing the opportunities and actions described above, there can be no assurance that it will be successful in its efforts. If the Company is unable to secure additional capital, it will explore other strategic alternatives, including, but not limited to, the sale of the Company. Any additional equity financing may result in substantial dilution to the Company’s stockholders.

Inventory

Inventory	9 Months Ended
	Sep. 30, 2014
Inventory [Abstract]	'
Inventory	'
	2.     Inventory
	As of September 30, 2014 and December 31, 2013, inventory consisted of parts and materials totaling $123,647 and $126,952, respectively.

Property_and_Equipment

Property and Equipment	9 Months Ended
	Sep. 30, 2014
Property and Equipment [Abstract]	'
Property and Equipment	'
	3.     Property and Equipment
	As of September 30, 2014 and December 31, 2013, property and equipment, on a net basis, consisted of the following (see note 7):
		September 30,			December 31,
		2014			2013
	Leasehold improvements	$	328,977		$	328,977
	Equipment		437,504			437,504
			766,481			766,481
	Less:  Accumulated depreciation		(485,659	)		(421,597	)
		$	280,822		$	344,884

Accrued_Expenses

Accrued Expenses	9 Months Ended
	Sep. 30, 2014
Accrued Expenses [Abstract]	'
Accrued Expenses	'
	4.     Accrued Expenses
	As of September 30, 2014 and December 31, 2013, accrued expenses consisted of the following:
		September 30,		December 31,
		2014		2013
	Accrued interest	$	55,054	$	24,321
	Accrued consulting fees		13,550		--
	Accrued auditing fees		2,750		22,000
	Accrued other expenses		2,765		1,633
		$	74,119	$	47,954

Customer_Deposits

Customer Deposits	9 Months Ended
	Sep. 30, 2014
Customer Deposits [Abstract]	'
Customer Deposits	'
	5.     Customer Deposits
	On March 29, 2011, the Company issued a credit to purchase equipment to a consultant in the amount of $36,109 as payment to the consultant for consulting services rendered to the Company.
	Effective January 1, 2013, the Company entered into a license agreement with a third party related to the use by the third party of the Company’s United States Environmental Protection Agency (the “EPA”) registration for its anolyte solution. The Company received a deposit of $2,000 pursuant to the terms of this agreement.

Convertible_Debentures

Convertible Debentures	9 Months Ended
	Sep. 30, 2014
Convertible Debentures [Abstract]	'
Convertible Debentures	'
	6.     Convertible Debentures
	April 2007 Convertible Debenture
	On April 26, 2007, in a private placement, the Company issued a convertible debenture to an individual accredited investor in the principal amount of $25,000. This convertible debenture matured on January 2, 2009 and remains unpaid. The convertible debenture accrues interest at a rate of 12% per annum and is convertible at any time into shares of the Company’s common stock at the option of the holder at a conversion price of $0.40 per share. An aggregate of 62,500 shares of the Company’s common stock can be issued upon the conversion of the outstanding principal amount due on this convertible debenture at the current conversion price of $0.40 per share.
	During the three and nine months ended September 30, 2014, the Company recorded $756 and $2,244, respectively, of interest expense related to this convertible debenture. During the three and nine months ended September 30, 2013, the Company recorded $748 and $2,236, respectively, of interest expense related to this convertible debenture. As of September 30, 2014 and December 31, 2013, the outstanding principal on this convertible debenture was $25,000 and the accrued and unpaid interest was $12,685 and $10,441, respectively. The accrued and unpaid interest is included as a component of accrued expenses.
	Zanett Convertible Debentures
	On August 21, 2012, the Company issued to Zanett Opportunity Fund, Ltd. (“Zanett”) an 8% convertible debenture in the amount of $476,125 (the “Zanett August 2012 Debenture”). In connection with this private placement, the Company refinanced an 8% convertible debenture, in the principal amount of $376,125, issued to Zanett on July 7, 2011 (the “Zanett July 2011 Debenture”) and refinanced an 8% convertible secured promissory note, in the principal amount of $100,000, issued to Zanett on September 23, 2011 (the “Zanett September 2011 Note”). As a result of the issuance of the Zanett August 2012 Debenture, the Zanett July 2011 Debenture and the Zanett September 2011 Note were cancelled.
	The Zanett August 2012 Debenture has a three-year term maturing on August 21, 2015 and bears interest at a rate of 8% per annum. Interest is payable in annual installments in cash or, at the option of the Company, in shares of the Company’s common stock. If the Company elects to pay the interest in shares of its common stock, the number of shares issued as payment will be equal to the quotient of the unpaid interest divided by the market price of the Company’s common stock, as defined in the Zanett August 2012 Debenture.
	The entire principal amount of the Zanett August 2012 Debenture is convertible at any time into shares of the Company’s common stock at the option of the holder at a conversion price of $0.10 per share. In addition, at the option of the Company, the entire principal amount of the Zanett August 2012 Debenture is convertible into shares of the Company’s common stock at $0.10 per share upon the occurrence of the merger or acquisition of the Company or if the average closing price of the Company’s common stock for any period of ten consecutive trading days is greater than or equal to $0.15 per share. The quoted market price of the Company’s common stock on August 21, 2012 was $0.05 per share. An aggregate of 4,761,250 shares of the Company’s common stock can be issued upon the conversion of the outstanding principal amount due on the Zanett August 2012 Debenture at the current conversion price of $0.10 per share.
	On August 22, 2013, the Company issued 400,947 shares of the Company’s common stock to Zanett as payment of $38,090 of accrued interest due on the Zanett August 2012 Debenture for the period commencing August 21, 2012 through August 20, 2013. The number of shares of the Company’s common stock issued as payment of the accrued interest was calculated based on the market price of the Company’s common stock ($0.095 per share) as defined in the Zanett August 2012 Debenture.
	During the three and nine months ended September 30, 2014, the Company recorded $9,601 and $28,489, respectively, of interest expense related to the Zanett August 2012 Debenture. During the three and nine months ended September 30, 2013, the Company recorded $9,338 and $28,489, respectively, of interest expense related to the Zanett August 2012 Debenture. As of September 30, 2014 and December 31, 2013, the outstanding principal on the Zanett August 2012 Debenture was $476,125 and the accrued and unpaid interest was $42,369 and $13,880, respectively. The accrued and unpaid interest is included as a component of accrued expenses.

Note_Payable

Note Payable	9 Months Ended
	Sep. 30, 2014
Note Payable [Abstract]	'
Note Payable	'
	7.     Note Payable
	On June 17, 2013, the Company and Benchmark Performance Group, Inc. (“Benchmark”) entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”), whereby the Company purchased nineteen EcaFlo™ machines owned by Benchmark as well as the rights to the Excelyte™ trademark and certain other intangible assets. The purchase price for the nineteen EcaFlo™ machines, the Excelyte™ trademark and other intangible assets was $190,000.
	The Company paid $38,000 in conjunction with the closing of the Asset Purchase Agreement and issued a promissory note with a principal balance of $152,000 (the “Benchmark Note”). The Benchmark Note bears interest at a rate of 7% per annum and requires the Company to make twenty-four monthly payments of $6,805 commencing August 1, 2013. The Benchmark Note is secured by the nineteen EcaFlo™ machines.
	For the three and nine months ended September 30, 2014, the Company recorded $1,376 and $5,111, respectively, of interest expense related to the Benchmark Note. As of September 30, 2014 and December 31, 2013, the outstanding principal on the Benchmark Note was $65,920 and $122,059 (current portion $75,513; long-term portion $46,546), respectively.

Stockholders_Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2014
Stockholders' Equity [Abstract]	'
Stockholders' Equity	'
	8.     Stockholders’ Equity
	Common Stock
	From July 22, 2014 through July 31, 2014, the Company sold an aggregate of 4,850,000 shares of its common stock to five individual investors for an aggregate purchase price of $198,400. The Company incurred offering costs of $8,256 in connection with these transactions.
	On July 31, 2014, the Company issued an aggregate of 286,364 shares of its common stock, at a per share price of $0.055, as settlement of $15,750 of director fees due certain members of the Company’s board of directors for services rendered for the period commencing January 1, 2014 through June 30, 2014. The quoted market price of the Company’s common stock on July 1, 2014, the date the issuance was approved by the Company’s board of directors, was $0.051 per share.
	From August 6, 2014 through August 18, 2014, the Company sold an aggregate of 8,122,287 shares of its common stock to five individual investors for an aggregate purchase price of $403,080. The Company incurred offering costs of $24,440 in connection with these transactions.
	On September 3, 2014 and September 15, 2014, the Company sold an aggregate of 2,241,406 shares of its common stock to two individual investors for an aggregate purchase price of $137,000. The Company incurred offering costs of $7,360 payable in cash and issued 98,361 shares of its common stock to an unaffiliated third party as payment of $6,000 of offering costs in connection with these transactions.
	Stock Options
	The Company currently has two stock option/stock compensation plans in place: the 2010 Stock Incentive Plan and the 2012 Equity Incentive Plan (collectively, the “Equity Incentive Plans”).
	The 2010 Stock Incentive Plan was approved by the stockholders in September 2010. The Company had reserved for issuance an aggregate of 10,000,000 shares of common stock under the 2010 Stock Incentive Plan. As of September 30, 2014, stock options to purchase 4,680,254 shares of the Company’s common stock were outstanding under the 2010 Stock Incentive Plan and 90,500 shares of the Company’s common stock had been issued under the 2010 Stock Incentive Plan. As a result of the adoption of the Company’s 2012 Equity Incentive Plan, no further awards are permitted under the 2010 Stock Incentive Plan.
	The 2012 Equity Incentive Plan was approved by the stockholders in May 2012. The Company has reserved for issuance an aggregate of 14,000,000 shares of common stock under the 2012 Stock Incentive Plan. The 2012 Equity Incentive Plan is designed to encourage and enable employees and directors of the Company to acquire, or increase their holdings of, common stock and other proprietary interests in the Company. It is intended to promote these individuals’ interests in the Company, thereby enhancing the efficiency, soundness, profitability, growth and stockholder value of the Company. The 2012 Equity Incentive Plan provides for grants and/or awards in the form of incentive and non-qualified stock option grants, stock appreciation rights, restricted stock awards, performance share awards, phantom stock awards and dividend equivalent awards. As of September 30, 2014, stock options to purchase 1,000,000 shares of the Company’s common stock were outstanding under the 2012 Equity Incentive Plan and up to 13,000,000 shares of the Company’s common stock remain available for awards under the 2012 Equity Incentive Plan.
	Common stock grants and stock option awards under the Equity Incentive Plans were granted or issued at prices as determined by the Company’s compensation committee; provided, however, that such prices were not less than the fair market value of the Company's common stock on the date of grant or issuance. Stock options granted and outstanding to date consist of both incentive stock options and non-qualified stock options.
	On August 18, 2014, the Company granted an incentive stock option to purchase an aggregate of 1,000,000 shares of the Company’s common stock under the 2012 Equity Incentive Plan to Bradley W. Rockman, the President and General Manager of the Company’s Oil and Gas division. The shares of common stock underlying the incentive stock option vest as follows: 250,000 shares vest on August 18, 2015; 250,000 shares vest on August 18, 2016; 250,000 shares vest on August 18, 2017; and 250,000 shares vest on August 18, 2018. The incentive stock option has a ten-year term, and in the event of a change in control of the Company, as defined in the 2012 Stock Incentive Plan, the incentive stock option becomes fully vested. The aggregate fair value of the incentive stock option on the date of grant, as calculated using the Black-Scholes model, was $57,035, using the following weighted average assumptions: exercise price of $0.09 per share; common stock price of $0.09 per share; volatility of 139%; term of ten years; dividend yield of 0%; interest rate of 2.39%; and risk of forfeiture of 35%. This amount is being expensed on a pro-rata basis over the requisite service period.
	A summary of stock option transactions under the Equity Incentive Plans during the nine months ended September 30, 2014 is set forth below:
			Stock				Weighted Average Exercise Price Per Common Share				Aggregate Intrinsic Value
			Option Shares
	Outstanding at December 31, 2013			4,980,254			$	0.18			$	--
	Granted during the period			1,000,000			$	0.09				--
	Exercised during the period			--				--				--
	Terminated during the period			300,000			$	0.08				--
	Outstanding at September 30, 2014			5,680,254			$	0.17			$	--
	Available for purchase at September 30, 2014			3,013,586			$	0.13			$	--
	Available for purchase at December 31, 2013			3,313,586			$	0.12			$	--
	Information with respect to stock options outstanding and stock options exercisable as of September 30, 2014 is as follows:
						Stock Options Outstanding										Stock Options Exercisable
		Exercise				Number of Shares Available Under Outstanding Stock				Weighted Average Exercise Price Per Common Share				Weighted Average Remaining Contractual Life (Years)		Number of Shares Available for Purchase Under Outstanding Stock Options		Weighted Average Exercise Price Per Common Share		Weighted Average Remaining Contractual Life (Years)
		Price				Options
	$	0.09				1,000,000			$	0.09				9.9		--		--		--
	$	0.1				2,180,253			$	0.1				4.4		2,180,253	$	0.1		4.4
	$	0.2				833,333			$	0.2				7.5		833,333	$	0.2		7.5
	$	0.3				1,666,668			$	0.3				7.5		--		--		--
						5,680,254			$	0.17				5		3,013,586	$	0.13		5.3
	A summary of the non-vested shares subject to stock options granted under the Equity Incentive Plans as of September 30, 2014 is as follows:
			Stock				Weighted Average Grant Date Fair Value
			Option Shares				Per Share
	Non-vested at December 31, 2013			1,666,668			$	0.05
	Granted during the period			1,000,000			$	0.09
	Vested during the period			--				--
	Terminated during the period			--				--
	Non-vested at September 30, 2014			2,666,668			$	0.07
	As of September 30, 2014, there was $62,729 of unrecognized compensation cost related to non-vested, stock-based compensation arrangements granted under the Equity Incentive Plans. That cost is expected to be recognized over a weighted average period of 3.5 years.
	Warrants to Purchase Common Stock
	A summary of warrant transactions during the nine months ended September 30, 2014 is as follows:
			Warrant Shares				Weighted Average Exercise Price Per Common Share				Aggregate Intrinsic Value
	Outstanding at December 31, 2013			36,844,565			$	0.12			$	--
	Issued during the period			500,000			$	0.06				--
	Exercised during the period			--				--				--
	Terminated during the period			(6,500,000	)		$	0.15				--
	Outstanding at September 30, 2014			30,844,565			$	0.12			$	--
	Available for purchase at September 30, 2014			30,844,565			$	0.12			$	--
	Available for purchase at December 31, 2013			36,844,565			$	0.12			$	--
	Warrants issued by the Company contain exercise prices that were approved by the Company’s board of directors. Such exercise prices are generally not less than the quoted market price of the Company's common stock on the date of issuance. Warrants currently issued either vested immediately or over a period of up to three years and have a maximum term of ten years from the date of issuance.
	Information with respect to warrants outstanding and warrants exercisable at September 30, 2014 is as follows:
					Warrants Outstanding										Warrants Exercisable
	Range of				Number of Shares Available Under Outstanding Warrants				Weighted Average Remaining Contractual Life (Years)				Weighted Average Exercise Price Per Common Share		Number of Shares Available for Purchase Under Outstanding Warrants		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price Per Common Share
	Exercise Prices
	$	0.03 - 0.04				1,151,567				2.3			$	0.04		1,151,567		2.3	$	0.04
	$	0.06 - 0.10				20,056,061				3.7			$	0.09		20,056,061		3.7	$	0.09
	$	0.2				9,636,937				0.6			$	0.2		9,636,937		0.6	$	0.2
						30,844,565				2.7			$	0.12		30,844,565		2.7	$	0.12
	As of September 30, 2014, there were no non-vested shares subject to warrants and no unrecognized compensation cost related to warrants.

StockBased_Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 30, 2014
Stock-Based Compensation [Abstract]	'
Stock-Based Compensation	'
	9.     Stock-Based Compensation
	During the three and nine months ended September 30, 2014 and 2013, the Company recorded stock-based compensation expense as follows:
		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2014		2013		2014		2013
	General and administrative	$	12,230	$	31,760	$	54,178	$	105,585
	Sales and marketing		4,256		2,576		9,324		7,644
	Research and development		1,104		1,104		3,276		3,276
		$	17,590	$	35,440	$	66,778	$	116,505
	For the three and nine months ended September 30, 2014, the Company recorded stock-based compensation expense related to stock options granted to employees and directors of $9,040 and $26,757, respectively. For the three and nine months ended September 30, 2014, the Company recorded stock-based compensation expense related to common stock and warrants granted to non-employees of $8,550 and $40,021, respectively.
	For the three and nine months ended September 30, 2013, the Company recorded stock-based compensation expense related to stock options granted to employees and directors of $12,252 and $36,355, respectively. For the three and nine months ended September 30, 2013, the Company recorded stock-based compensation expense related to common stock and warrants granted to non-employees of $23,188 and $80,150, respectively.

Net_Loss_Per_Common_Share

Net Loss Per Common Share	9 Months Ended
	Sep. 30, 2014
Net Loss Per Common Share [Abstract]	'
Net Loss Per Common Share	'
	10.     Net Loss Per Common Share
	Basic net loss per share is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflect, in periods in which they have a dilutive effect, the impact of common shares issuable upon exercise of stock options and warrants and conversion of convertible debt that are not deemed to be anti-dilutive. The dilutive effect of the outstanding stock options and warrants is computed using the treasury stock method.
	For the three and nine months ended September 30, 2014, diluted net loss per share did not include the effect of 5,680,254 shares of common stock issuable upon the exercise of outstanding stock options, 30,844,565 shares of common stock issuable upon the exercise of outstanding warrants and 4,823,750 shares of common stock issuable upon the conversion of convertible debt, as their effect would be anti-dilutive.
	For the three and nine months ended September 30, 2013, diluted net loss per share did not include the effect of 5,813,587 shares of common stock issuable upon the exercise of outstanding stock options, 46,779,565 shares of common stock issuable upon the exercise of outstanding warrants and 4,823,750 shares of common stock issuable upon the conversion of convertible debt, as their effect would be anti-dilutive.

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	11.     Commitments and Contingencies
	Lease Agreement – South Carolina
	On September 15, 2014, the Company entered into a lease agreement for its premises located in Little River, South Carolina. The lease agreement has an initial term of three years and is renewable at the Company’s option for two successive three-year terms. The monthly rental during the initial term of the lease agreement is $4,800. The Company is responsible for utilities but is not responsible for building insurance or property taxes. As of September 30, 2014, the future minimum lease payments due under this lease agreement are as follows: $14,400 for the remainder of 2014, $57,600 in each of fiscal 2015 and fiscal 2016, and $43,200 in fiscal 2017.
	Litigation with Former Executive Vice President - Operations
	On June 17, 2014, a civil complaint was filed against the Company and one of its directors, E. Wayne Kinsey, III, in the Court of Common Pleas, County of Horry, State of South Carolina, by Marion Sofield, the Company’s former Executive Vice President - Operations. In her complaint, Ms. Sofield alleges breach of contract and fraudulent inducement by the Company against her with regard to her employment agreement and the termination of her employment. Ms. Sofield also alleges civil conspiracy, tortious interference and unfair trade practices. Ms. Sofield claims that she is owed additional compensation under her terminated employment agreement, and is seeking the recovery of such compensation as well as attorney’s fees and punitive damages.
	On July 18, 2014, the Company filed a motion to dismiss this state court action due to the binding arbitration clause contained in Ms. Sofield’s employment agreement. This motion is currently pending.
	The Company does not believe there is any merit to Ms. Sofield’s allegations and will vigorously defend this action.

Subsequent_Events

Subsequent Events	9 Months Ended
	Sep. 30, 2014
Subsequent Events [Abstract]	'
Subsequent Events	'
	12.     Subsequent Events
	On October 10, 2014, the Company sold an aggregate of 5,410,000 shares of its common stock to two individual investors for an aggregate purchase price of $330,010. The Company issued an aggregate of 541,000 shares of its common stock to three unaffiliated third parties as payment of $33,000 of offering costs related to this transaction.
	On October 10, 2014, the Company issued 437,816 shares of the Company’s common stock to Zanett as payment of $38,090 of accrued interest due on the Zanett August 2012 Debenture for the period commencing August 21, 2013 through August 20, 2014. The number of shares of the Company’s common stock issued as payment of the accrued interest was calculated based on the market price of the Company’s common stock ($0.087 per share) as defined in the Zanett August 2012 Debenture.

Property_and_Equipment_Tables

Property and Equipment (Tables)	9 Months Ended
	Sep. 30, 2014
Property and Equipment [Abstract]	'
Components of property and equipment, on a net basis	'
		September 30,			December 31,
		2014			2013
	Leasehold improvements	$	328,977		$	328,977
	Equipment		437,504			437,504
			766,481			766,481
	Less:  Accumulated depreciation		(485,659	)		(421,597	)
		$	280,822		$	344,884

Accrued_Expenses_Tables

Accrued Expenses (Tables)	9 Months Ended
	Sep. 30, 2014
Accrued Expenses [Abstract]	'
Components of accrued expenses	'
		September 30,		December 31,
		2014		2013
	Accrued interest	$	55,054	$	24,321
	Accrued consulting fees		13,550		--
	Accrued auditing fees		2,750		22,000
	Accrued other expenses		2,765		1,633
		$	74,119	$	47,954

Stockholders_Equity_Tables

Stockholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2014
Stock Options [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Schedule of s stock option and warrants transactions under the Equity Incentive Plan	'
			Stock				Weighted Average Exercise Price Per Common Share				Aggregate Intrinsic Value
			Option Shares
	Outstanding at December 31, 2013			4,980,254			$	0.18			$	--
	Granted during the period			1,000,000			$	0.09				--
	Exercised during the period			--				--				--
	Terminated during the period			300,000			$	0.08				--
	Outstanding at September 30, 2014			5,680,254			$	0.17			$	--
	Available for purchase at September 30, 2014			3,013,586			$	0.13			$	--
	Available for purchase at December 31, 2013			3,313,586			$	0.12			$	--
Schedule of share-based compensation, outstanding options and options exercisable	'
						Stock Options Outstanding										Stock Options Exercisable
		Exercise				Number of Shares Available Under Outstanding Stock				Weighted Average Exercise Price Per Common Share				Weighted Average Remaining Contractual Life (Years)		Number of Shares Available for Purchase Under Outstanding Stock Options		Weighted Average Exercise Price Per Common Share		Weighted Average Remaining Contractual Life (Years)
		Price				Options
	$	0.09				1,000,000			$	0.09				9.9		--		--		--
	$	0.1				2,180,253			$	0.1				4.4		2,180,253	$	0.1		4.4
	$	0.2				833,333			$	0.2				7.5		833,333	$	0.2		7.5
	$	0.3				1,666,668			$	0.3				7.5		--		--		--
						5,680,254			$	0.17				5		3,013,586	$	0.13		5.3
Schedule of nonvested share activity	'
			Stock				Weighted Average Grant Date Fair Value
			Option Shares				Per Share
	Non-vested at December 31, 2013			1,666,668			$	0.05
	Granted during the period			1,000,000			$	0.09
	Vested during the period			--				--
	Terminated during the period			--				--
	Non-vested at September 30, 2014			2,666,668			$	0.07
Warrants [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Schedule of s stock option and warrants transactions under the Equity Incentive Plan	'
			Warrant Shares				Weighted Average Exercise Price Per Common Share				Aggregate Intrinsic Value
	Outstanding at December 31, 2013			36,844,565			$	0.12			$	--
	Issued during the period			500,000			$	0.06				--
	Exercised during the period			--				--				--
	Terminated during the period			(6,500,000	)		$	0.15				--
	Outstanding at September 30, 2014			30,844,565			$	0.12			$	--
	Available for purchase at September 30, 2014			30,844,565			$	0.12			$	--
	Available for purchase at December 31, 2013			36,844,565			$	0.12			$	--
Schedule of share-based compensation, outstanding options and options exercisable	'
					Warrants Outstanding										Warrants Exercisable
	Range of				Number of Shares Available Under Outstanding Warrants				Weighted Average Remaining Contractual Life (Years)				Weighted Average Exercise Price Per Common Share		Number of Shares Available for Purchase Under Outstanding Warrants		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price Per Common Share
	Exercise Prices
	$	0.03 - 0.04				1,151,567				2.3			$	0.04		1,151,567		2.3	$	0.04
	$	0.06 - 0.10				20,056,061				3.7			$	0.09		20,056,061		3.7	$	0.09
	$	0.2				9,636,937				0.6			$	0.2		9,636,937		0.6	$	0.2
						30,844,565				2.7			$	0.12		30,844,565		2.7	$	0.12

StockBased_Compensation_Tables

Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2014
Stock-Based Compensation [Abstract]	'
Schedule of recognized stock-based compensation expense	'
		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2014		2013		2014		2013
	General and administrative	$	12,230	$	31,760	$	54,178	$	105,585
	Sales and marketing		4,256		2,576		9,324		7,644
	Research and development		1,104		1,104		3,276		3,276
		$	17,590	$	35,440	$	66,778	$	116,505

Basis_of_Presentation_Details

Basis of Presentation (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Basis of Presentation (Textual)	'	'
Working capital deficiency	$99,629	'
Accumulated deficit	($20,938,646)	($19,480,652)

Inventory_Details

Inventory (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Inventory (Textual)	'	'
Inventory parts and materials	$123,647	$126,952

Property_and_Equipment_Details

Property and Equipment (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Components of property and equipment, on a net basis	'	'
Leasehold improvements	$328,977	$328,977
Equipment	437,504	437,504
Property and equipment, Gross	766,481	766,481
Less: Accumulated depreciation	-485,659	-421,597
Property and equipment, net	$280,822	$344,884

Accrued_Expenses_Details

Accrued Expenses (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Components of accrued expenses	'	'
Accrued interest	$55,054	$24,321
Accrued consulting fees	13,550	'
Accrued auditing fees	2,750	22,000
Accrued other expenses	2,765	1,633
Accrued liabilities, total	$74,119	$47,954

Customer_Deposits_Details

Customer Deposits (Details) (USD $)	0 Months Ended
	Mar. 29, 2011	Sep. 30, 2014
Customer Deposits (Textual)	'	'
Deposit received	'	$2,000
Consulting services	$36,109	'

Convertible_Debentures_Details

Convertible Debentures (Details) (USD $)

3 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2014

Dec. 31, 2013

Apr. 26, 2007

Sep. 30, 2014

Sep. 30, 2014

Dec. 31, 2013

Aug. 22, 2013

Aug. 21, 2012

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Aug. 20, 2013

Dec. 31, 2013

Jul. 07, 2011

Sep. 23, 2011

April 2007 Convertible Debenture [Member]

April 2007 Convertible Debenture [Member]

April 2007 Convertible Debenture [Member]

April 2007 Convertible Debenture [Member]

Zanett August 2012 Debenture [Member]

Zanett August 2012 Debenture [Member]

Zanett August 2012 Debenture [Member]

Zanett August 2012 Debenture [Member]

Zanett August 2012 Debenture [Member]

Zanett August 2012 Debenture [Member]

Zanett August 2012 Debenture [Member]

Zanett August 2012 Debenture [Member]

Zanett July 2011 Debenture [Member]

Zanett September 2011 Note [Member]

Convertible Debentures (Textual)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible debenture issued, Principal amount

'

'

'

'

$25,000

'

'

'

'

$476,125

'

'

'

'

'

'

$376,125

$100,000

Convertible debenture, Maturity Date

'

'

'

'

2-Jan-09

'

'

'

'

21-Aug-15

'

'

'

'

'

'

'

'

Convertible debenture, Interest Rate

'

'

'

'

12.00%

'

'

'

'

8.00%

'

'

'

'

'

'

8.00%

8.00%

Interest expense

748

2,236

'

'

'

756

2,244

'

'

'

9,601

9,338

28,489

28,489

'

'

'

'

Common stock issued pursuant to the Secured Notes

'

'

'

'

'

'

'

'

'

4,761,250

'

'

'

'

'

'

'

'

Outstanding principal

'

'

'

476,125

'

25,000

25,000

25,000

'

'

476,125

'

476,125

'

'

476,125

'

'

Accrued and unpaid interest on convertible debt

'

'

'

'

'

12,685

12,685

10,441

38,090

'

42,369

'

42,369

'

'

13,880

'

'

Promissory notr convertible debenture, Interest rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

8.00%

'

Convertible debenture, Conversion Price

'

'

'

'

$0.40

'

'

'

'

$0.10

'

'

'

'

'

'

'

'

Common stock issued as payment on principal and interest on convertible debentures, shares

'

'

'

'

62,500

'

'

'

'

'

'

'

'

'

'

'

'

'

Condition for conversion of debt amount to common stock

'

'

'

'

'

'

'

'

'

'

'

'

'The occurrence of the merger or acquisition of the Company or if the average closing price of the Company's common stock for any period of ten consecutive trading days is greater than or equal to $0.15 per share.

'

'

'

'

'

Convertible debenture maturity term

'

'

'

'

'

'

'

'

'

'3 years

'

'

'

'

'

'

'

'

Common stock market price

'

'

'

'

'

'

'

'

$0.10

$0.05

'

'

'

'

$0.10

'

'

'

Common stock issued for payment of interest, shares

'

'

'

'

'

'

'

'

400,947

'

'

'

'

'

'

'

'

'

Accrued interest

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$38,090

'

'

'

Note_Payable_Details

Note Payable (Details) (USD $)	3 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2014	Dec. 31, 2013
		Machine
Note Payable (Textual)	'	'	'
Notes payable current portion	$65,920	$65,920	$75,513
Note payable long term portion	'	'	46,546
Asset Purchase Agreement [Member]	'	'	'
Note Payable (Textual)	'	'	'
Number of machines purchase agreement	'	19	'
Purchase price of asset	'	190,000	'
Payment in closing of asset purchase agreement	'	38,000	'
Issuance of promissory note principal balance	'	152,000	'
Convertible promissory notes, interest percentage	7.00%	7.00%	'
Convertible promissory notes, maturity date	'	1-Aug-13	'
Periodic payment	'	6,805	'
Description of payment term	'	'Twenty-four monthly payments.	'
Interest expense	1,376	5,111	'
Notes Payable	65,920	65,920	122,059
Notes payable current portion	'	'	75,513
Note payable long term portion	'	'	$46,546

Stockholders_Equity_Details

Stockholders' Equity (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
Stock Options [Member]	'
Summary of stock option and warrant transactions	'
Outstanding, Number, Beginning Balance	4,980,254
Granted during the period, Shares	1,000,000
Exercised during the period, Shares	'
Terminated during the period, Shares	300,000
Outstanding shares, Ending balance	5,680,254
Available for purchase, Ending Balance	3,013,586
Available for purchase, Beginning Balance	3,313,586
Outstanding, Weighted Average Exercise Price, Beginning Balance	$0.18
Grants in Period, Weighted Average Exercise Price	$0.09
Exercises in Period, Weighted Average Exercise Price	'
Terminated, Weighted Average Exercise Price	$0.08
Outstanding, Weighted Average Exercise Price, Ending balance	$0.17
Available for purchase, Weighted Average Exercise Price, Ending balance	$0.13
Available for purchase, Weighted Average Exercise Price, Beginning balance	$0.12
Outstanding, Intrinsic Value	'
Granted Aggregate Intrinsic Value	'
Exercised Aggregate Intrinsic Value	'
Terminated Aggregate Intrinsic Value	'
Outstanding, Aggregate Intrinsic Value, Ending balance	'
Available for purchase, Intrinsic Value, Ending Balance	'
Available for purchase, Intrinsic Value, Beginning Balance	'
Warrants [Member]	'
Summary of stock option and warrant transactions	'
Outstanding, Number, Beginning Balance	36,844,565
Granted during the period, Shares	500,000
Exercised during the period, Shares	'
Terminated during the period, Shares	-6,500,000
Outstanding shares, Ending balance	30,844,565
Available for purchase, Ending Balance	30,844,565
Available for purchase, Beginning Balance	30,844,565
Outstanding, Weighted Average Exercise Price, Beginning Balance	$0.12
Grants in Period, Weighted Average Exercise Price	$0.06
Exercises in Period, Weighted Average Exercise Price	'
Terminated, Weighted Average Exercise Price	$0.15
Outstanding, Weighted Average Exercise Price, Ending balance	$0.12
Available for purchase, Weighted Average Exercise Price, Ending balance	$0.12
Available for purchase, Weighted Average Exercise Price, Beginning balance	$0.12
Outstanding, Intrinsic Value	'
Granted Aggregate Intrinsic Value	'
Exercised Aggregate Intrinsic Value	'
Terminated Aggregate Intrinsic Value	'
Outstanding, Aggregate Intrinsic Value, Ending balance	'
Available for purchase, Intrinsic Value, Ending Balance	'
Available for purchase, Intrinsic Value, Beginning Balance	'

Stockholders_Equity_Details_1

Stockholders' Equity (Details 1) (USD $)	9 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Stock Options [Member]	'	'
Summary of stock option and warrant transactions	'	'
Stock Options Outstanding, Number of Shares Available under outstanding Option/warrant	5,680,254	4,980,254
Stock Options Outstanding, Weighted Average Exercise Price Per Common Share	$0.17	$0.18
Stock Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'5 years	'
Stock Options Exercisable, Number of Shares Available for Purchase Under Outstanding stock	3,013,586	'
Stock Options Exercisable, Weighted Average Exercise Price Per Common Share	$0.13	'
Stock Options Exercisable, Weighted Average Remaining Contractual Life (Years)	'5 years 3 months 18 days	'
Stock Options [Member] | Range 1 [Member]	'	'
Summary of stock option and warrant transactions	'	'
Range of exercise prices	$0.09	'
Stock Options Outstanding, Number of Shares Available under outstanding Option/warrant	1,000,000	'
Stock Options Outstanding, Weighted Average Exercise Price Per Common Share	$0.09	'
Stock Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'9 years 10 months 24 days	'
Stock Options Exercisable, Number of Shares Available for Purchase Under Outstanding stock	'	'
Stock Options Exercisable, Weighted Average Exercise Price Per Common Share	'	'
Stock Options [Member] | Range 2 [Member]	'	'
Summary of stock option and warrant transactions	'	'
Range of exercise prices	$0.10	'
Stock Options Outstanding, Number of Shares Available under outstanding Option/warrant	2,180,253	'
Stock Options Outstanding, Weighted Average Exercise Price Per Common Share	$0.10	'
Stock Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'4 years 4 months 24 days	'
Stock Options Exercisable, Number of Shares Available for Purchase Under Outstanding stock	2,180,253	'
Stock Options Exercisable, Weighted Average Exercise Price Per Common Share	$0.10	'
Stock Options Exercisable, Weighted Average Remaining Contractual Life (Years)	'4 years 4 months 24 days	'
Stock Options [Member] | Range 3 [Member]	'	'
Summary of stock option and warrant transactions	'	'
Range of exercise prices	$0.20	'
Stock Options Outstanding, Number of Shares Available under outstanding Option/warrant	833,333	'
Stock Options Outstanding, Weighted Average Exercise Price Per Common Share	$0.20	'
Stock Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'7 years 6 months	'
Stock Options Exercisable, Number of Shares Available for Purchase Under Outstanding stock	833,333	'
Stock Options Exercisable, Weighted Average Exercise Price Per Common Share	$0.20	'
Stock Options Exercisable, Weighted Average Remaining Contractual Life (Years)	'7 years 6 months	'
Stock Options [Member] | Range 4 [Member]	'	'
Summary of stock option and warrant transactions	'	'
Range of exercise prices	$0.30	'
Stock Options Outstanding, Number of Shares Available under outstanding Option/warrant	1,666,668	'
Stock Options Outstanding, Weighted Average Exercise Price Per Common Share	$0.30	'
Stock Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'7 years 6 months	'
Stock Options Exercisable, Number of Shares Available for Purchase Under Outstanding stock	'	'
Stock Options Exercisable, Weighted Average Exercise Price Per Common Share	'	'
Warrant [Member]	'	'
Summary of stock option and warrant transactions	'	'
Stock Options Outstanding, Number of Shares Available under outstanding Option/warrant	30,844,565	36,844,565
Stock Options Outstanding, Weighted Average Exercise Price Per Common Share	$0.12	$0.12
Stock Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'2 years 8 months 12 days	'
Stock Options Exercisable, Number of Shares Available for Purchase Under Outstanding stock	30,844,565	'
Stock Options Exercisable, Weighted Average Exercise Price Per Common Share	$0.12	'
Stock Options Exercisable, Weighted Average Remaining Contractual Life (Years)	'2 years 8 months 12 days	'
Warrant [Member] | Range 1 [Member]	'	'
Summary of stock option and warrant transactions	'	'
Range of exercise prices, Lower limit	$0.03	'
Range of exercise prices, Upper limit	$0.04	'
Stock Options Outstanding, Number of Shares Available under outstanding Option/warrant	1,151,567	'
Stock Options Outstanding, Weighted Average Exercise Price Per Common Share	$0.04	'
Stock Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'2 years 3 months 18 days	'
Stock Options Exercisable, Number of Shares Available for Purchase Under Outstanding stock	1,151,567	'
Stock Options Exercisable, Weighted Average Exercise Price Per Common Share	$0.04	'
Stock Options Exercisable, Weighted Average Remaining Contractual Life (Years)	'2 years 3 months 18 days	'
Warrant [Member] | Range 2 [Member]	'	'
Summary of stock option and warrant transactions	'	'
Range of exercise prices, Lower limit	$0.06	'
Range of exercise prices, Upper limit	$0.10	'
Stock Options Outstanding, Number of Shares Available under outstanding Option/warrant	20,056,061	'
Stock Options Outstanding, Weighted Average Exercise Price Per Common Share	$0.09	'
Stock Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'3 years 8 months 12 days	'
Stock Options Exercisable, Number of Shares Available for Purchase Under Outstanding stock	20,056,061	'
Stock Options Exercisable, Weighted Average Exercise Price Per Common Share	$0.09	'
Stock Options Exercisable, Weighted Average Remaining Contractual Life (Years)	'3 years 8 months 12 days	'
Warrant [Member] | Range 3 [Member]	'	'
Summary of stock option and warrant transactions	'	'
Range of exercise prices	$0.20	'
Stock Options Outstanding, Number of Shares Available under outstanding Option/warrant	9,636,937	'
Stock Options Outstanding, Weighted Average Exercise Price Per Common Share	$0.20	'
Stock Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'7 months 6 days	'
Stock Options Exercisable, Number of Shares Available for Purchase Under Outstanding stock	9,636,937	'
Stock Options Exercisable, Weighted Average Exercise Price Per Common Share	$0.20	'
Stock Options Exercisable, Weighted Average Remaining Contractual Life (Years)	'7 months 6 days	'

Stockholders_Equity_Details_2

Stockholders' Equity (Details 2) (Stock Options [Member], USD $)	9 Months Ended
	Sep. 30, 2014
Stock Options [Member]	'
Summary of the non-vested shares subject to options granted/Warrant	'
Nonvested, Number, Beginning Balance	1,666,668
Granted during the period	1,000,000
Vested during the period	'
Terminated during the period	'
Non-vested Balance	2,666,668
Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance	$0.05
Weighted Average Grant Date Fair Value Per Share, Granted	$0.09
Weighted Average Grant Date Fair Value Per Share, Vested	'
Weighted Average Grant Date Fair Value Per Share, Terminated	'
Weighted Average Grant Date Fair Value Per Share, Ending Balance	$0.07

Stockholders_Equity_Details_Te

Stockholders' Equity (Details Textual) (USD $)	0 Months Ended				9 Months Ended		9 Months Ended		9 Months Ended		0 Months Ended
	Sep. 15, 2014	Aug. 18, 2014	Jul. 31, 2014	Jul. 31, 2014	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2014	Sep. 30, 2014	Aug. 18, 2014
	Investor	Investor	Investor	Board of Directors [Member]	Stock Options [Member]	Stock Options [Member]	Warrants [Member]	Warrants [Member]	2010 Stock Incentive Plan [Member]	2012 Equity Incentive Plan [Member]	2012 Equity Incentive Plan [Member]
											Stock Options [Member]
Stockholders Deficiency (Textual)	'	'	'	'	'	'	'	'	'	'	'
Common Stock Reserved	'	'	'	'	'	'	'	'	10,000,000	14,000,000	'
Common Stock Issued under incentive plan	'	'	'	'	'	'	'	'	90,500	13,000,000	'
Outstanding shares under stock option plan	'	'	'	'	5,680,254	4,980,254	30,844,565	36,844,565	4,680,254	1,000,000	'
Total unrecognized compensation cost related to non-vested stock-based compensation arrangements	'	'	'	'	'	'	'	'	'	$62,729	'
Cost expected to be recognized over weighted average period	'	'	'	'	'	'	'	'	'	'3 years 6 months	'
Minimum vesting period of warrant	'	'	'	'	'	'	'3 years	'	'	'	'
Maximum vesting period of warrant	'	'	'	'	'	'	'10 years	'	'	'	'
Issued during the period, Shares	'	'	'	'	1,000,000	'	500,000	'	'	'	1,000,000
Grants in Period, Weighted Average Exercise Price	'	'	'	'	$0.09	'	$0.06	'	'	'	'
Fair value of warrant	'	'	'	'	'	'	'	'	'	'	57,035
Exercise price	'	'	'	'	'	'	'	'	'	'	$0.09
Common stock price	'	'	'	$0.06	'	'	'	'	'	'	$0.09
Expected volatility rate	'	'	'	'	'	'	'	'	'	'	139.00%
Expected term	'	'	'	'	'	'	'	'	'	'	'10 years
Dividend yield	'	'	'	'	'	'	'	'	'	'	0.00%
Risk free interest rate	'	'	'	'	'	'	'	'	'	'	2.39%
Forfeiture rate	'	'	'	'	'	'	'	'	'	'	35.00%
Common stock issued, Shares	2,241,406	8,122,287	4,850,000	286,364	'	'	'	'	'	'	'
Common stock issued, Value	137,000	403,080	198,400	'	'	'	'	'	'	'	'
Common Stock, Market price per share	'	'	'	$0.05	'	'	'	'	'	'	'
Offering costs	7,360	24,440	8,256	'	'	'	'	'	'	'	'
Director fees	'	'	'	15,750	'	'	'	'	'	'	'
Number of individual investors	2	5	5	'	'	'	'	'	'	'	'
Common stock Issued to an unaffiliated third party, Shares	98,361	'	'	'	'	'	'	'	'	'	'
Common stock Issued to an unaffiliated third party, Value	$6,000	'	'	'	'	'	'	'	'	'	'
Stock option, Description	'	'	'	'	'	'	'	'	'	'	'The shares of common stock underlying the incentive stock option vest as follows: 250,000 shares vest on August 18, 2015; 250,000 shares vest on August 18, 2016; 250,000 shares vest on August 18, 2017; and 250,000 shares vest on August 18, 2018.
Options vested, Number of shares	'	'	'	'	'	'	'	'	'	'	250,000
Incentive stock option term	'	'	'	'	'	'	'	'	'	'	'10 years

StockBased_Compensation_Detail

Stock-Based Compensation (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Schedule of recognized stock-based compensation expense	'	'	'	'
Stock-based compensation expense	$17,590	$35,440	$66,778	$116,505
General and administrative [Member]	'	'	'	'
Schedule of recognized stock-based compensation expense	'	'	'	'
Stock-based compensation expense	12,230	31,760	54,178	105,585
Sales and marketing [Member]	'	'	'	'
Schedule of recognized stock-based compensation expense	'	'	'	'
Stock-based compensation expense	4,256	2,576	9,324	7,644
Research and development [Member]	'	'	'	'
Schedule of recognized stock-based compensation expense	'	'	'	'
Stock-based compensation expense	$1,104	$1,104	$3,276	$3,276

StockBased_Compensation_Detail1

Stock-Based Compensation (Details Textual) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Employees and directors [Member]	'	'	'	'
Stock Based Compensation (Textual)	'	'	'	'
Stock based compensation expense related to stock options	$9,040	$12,252	$26,757	$36,355
Non-employees [Member]	'	'	'	'
Stock Based Compensation (Textual)	'	'	'	'
Stock based compensation expense related to stock options	$8,550	$23,188	$40,021	$80,150

Net_Loss_Per_Common_Share_Deta

Net Loss Per Common Share (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Stock Options [Member]	'	'	'	'
Net Loss Per Common Share (Textual)	'	'	'	'
Anti-dilutive securities	5,680,254	5,813,587	5,680,254	5,813,587
Warrants [Member]	'	'	'	'
Net Loss Per Common Share (Textual)	'	'	'	'
Anti-dilutive securities	30,844,565	46,779,565	30,844,565	46,779,565
Convertible debt [Member]	'	'	'	'
Net Loss Per Common Share (Textual)	'	'	'	'
Anti-dilutive securities	4,823,750	4,823,750	4,823,750	4,823,750

Commitments_and_Contingencies_

Commitments and Contingencies (Details) (USD $)	0 Months Ended
	Sep. 15, 2014	Sep. 30, 2014
Commitments And Contingencies (Textual)	'	'
Rent expense	$4,800	'
Operating leases, Term of contract	'3 years	'
Operating leases, Renewal term	'3 years	'
Future minimum lease payments due 2014	'	14,400
Future minimum lease payments due 2015 and fiscal 2016	'	57,600
Future minimum lease payments due 2017	'	$43,200

Subsequent_Events_Details

Subsequent Events (Details) (USD $)	0 Months Ended
	Sep. 15, 2014	Aug. 18, 2014	Jul. 31, 2014	Oct. 10, 2014	Oct. 10, 2014
	Investor	Investor	Investor	Subsequent Event [Member]	Subsequent Event [Member]
				Investor	Zanett [Member]
Subsequent Event Textual [Abstract]	'	'	'	'	'
Common stock issued, Shares	2,241,406	8,122,287	4,850,000	5,410,000	437,816
Common stock issued, Value	$137,000	$403,080	$198,400	$330,010	'
Number of individual investors	2	5	5	2	'
Common stock Issued to an unaffiliated third party, Shares	98,361	'	'	541,000	'
Common stock Issued to an unaffiliated third party, Value	6,000	'	'	33,000	'
Common Stock, Market price per share	'	'	'	'	$0.09
Accrued interest due	'	'	'	'	$38,090